|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: SYNERGY TECHNOLOGIES CORP, 10QSB/A, EX-10, 2000-11-14 |
Next: ARENA PHARMACEUTICALS INC, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED FINANCIAL STATEMENTS OF SYNERGY TECHNOLOGIES CORPORATION AS AT
SEPTEMBER 30,2000 AND IS QUALIFED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> SEP-30-2000
<CASH> 685,987
<SECURITIES> 0
<RECEIVABLES> 1,035,639
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 1,785,232
<PP&E> 45,456
<DEPRECIATION> 9,330
<TOTAL-ASSETS> 2,993,188
<CURRENT-LIABILITIES> 1,197,702
<BONDS> 2,250,000
0
0
<COMMON> 7,258,388
<OTHER-SE> (7,579,318)
<TOTAL-LIABILITY-AND-EQUITY> 2,993,188
<SALES> 0
<TOTAL-REVENUES> 18,847
<CGS> 0
<TOTAL-COSTS> 2,589,780
<OTHER-EXPENSES> 2,250,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (4,820,933)
<INCOME-TAX> 0
<INCOME-CONTINUING> (4,820,933)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (4,820,933)
<EPS-BASIC> (0.39)
<EPS-DILUTED> (0.39)
</TABLE>
|
|